Literature DB >> 17530264

Surgical intervention in children with Crohn's disease.

R Leonor1, K Jacobson, V Pinsk, E Webber, D A Lemberg.   

Abstract

INTRODUCTION: Crohn's disease (CD) causes chronic inflammation of the gastrointestinal tract leading to extensive medical treatments and surgery with two thirds of patients having surgery over their lifetime. In this study, we reviewed the pediatric population at the British Columbia Children's Hospital diagnosed with CD and examined their demographics and treatments, in particular assessing those who ultimately underwent surgery.
MATERIALS AND METHODS: Two hundred and eighty children (median age 11.9 years [CI 11.5-12.28]) diagnosed with CD from January 1994 to December 2003 were included. Demographic data were documented including age, ethnicity, duration of symptoms before diagnosis, treatment to date and surgical parameters. Comparison was made between operative and non-operative patients including involvement of disease, medical treatment, complications and recurrence of disease leading to repeat operations.
RESULTS: Fifty-five (19.6%) children had surgical procedures. There was a significant increase in surgery in those patients who had not received immunomodulator therapy before surgery (odds ratio 1.95 [CI 1.02-3.73]). We also observed that those CD patients with extensive small intestinal involvement had lower likelihood of having surgery (odds ratio 0.386 [CI 0.145-1.033]). No significant difference was found between the two groups with regard to age of diagnosis (p = 0.41), duration of symptoms (p = 0.22), gender (p = 0.50) or ethnicity (p = 0.451).
CONCLUSION: There was an increased incidence of surgery in those patients who were not treated with immunomodulator therapy. In addition, children with extensive as opposed to isolated small intestinal disease were less likely to have surgery in childhood.

Entities:  

Mesh:

Year:  2007        PMID: 17530264     DOI: 10.1007/s00384-007-0281-3

Source DB:  PubMed          Journal:  Int J Colorectal Dis        ISSN: 0179-1958            Impact factor:   2.571


  17 in total

1.  Introduction of 6-mercaptopurine in Crohn's disease patients during the perioperative period: a preliminary evaluation of recurrence of disease.

Authors:  H A Kader; S C Raynor; R Young; S S Kaufman; J Vanderhoof; E I Ruby; D R Mack
Journal:  J Pediatr Gastroenterol Nutr       Date:  1997-07       Impact factor: 2.839

Review 2.  Inflammatory bowel disease.

Authors:  Daniel K Podolsky
Journal:  N Engl J Med       Date:  2002-08-08       Impact factor: 91.245

3.  A controlled double blind study of azathioprine in the management of Crohn's disease.

Authors:  S Candy; J Wright; M Gerber; G Adams; M Gerig; R Goodman
Journal:  Gut       Date:  1995-11       Impact factor: 23.059

4.  Azathioprine for prevention of postoperative recurrence in Crohn's disease: a retrospective study.

Authors:  E Cuillerier; M Lémann; Y Bouhnik; M Allez; J C Rambaud; R Modigliani
Journal:  Eur J Gastroenterol Hepatol       Date:  2001-11       Impact factor: 2.566

Review 5.  An historical overview of the treatment of Crohn's disease: why do we need biological therapies?

Authors:  Paul J Rutgeerts
Journal:  Rev Gastroenterol Disord       Date:  2004

6.  Fate of the pouch in 151 pediatric patients after ileal pouch anal anastomosis.

Authors:  Frederick Alexander; Samra Sarigol; John DiFiore; Anthony Stallion; Kathy Cotman; Holly Clark; Barb Lydzinski; Victor Fazio
Journal:  J Pediatr Surg       Date:  2003-01       Impact factor: 2.545

7.  Epidemiologic and clinical characteristics of children with newly diagnosed inflammatory bowel disease in Wisconsin: a statewide population-based study.

Authors:  Subra Kugathasan; Robert H Judd; Raymond G Hoffmann; Janice Heikenen; Gregorz Telega; Farhat Khan; Sally Weisdorf-Schindele; William San Pablo; Jean Perrault; Roger Park; Michael Yaffe; Christopher Brown; Maria T Rivera-Bennett; Issam Halabi; Alfonso Martinez; Ellen Blank; Steven L Werlin; Colin D Rudolph; David G Binion
Journal:  J Pediatr       Date:  2003-10       Impact factor: 4.406

8.  Cumulative experience with short- and long-term toxicity to 6-mercaptopurine in the treatment of Crohn's disease and ulcerative colitis.

Authors:  Jonathan I Warman; Burton I Korelitz; Mark R Fleisher; Ram Janardhanam
Journal:  J Clin Gastroenterol       Date:  2003-09       Impact factor: 3.062

9.  Long-term follow-up of patients with Crohn's disease treated with azathioprine or 6-mercaptopurine.

Authors:  Y Bouhnik; M Lémann; J Y Mary; G Scemama; R Taï; C Matuchansky; R Modigliani; J C Rambaud
Journal:  Lancet       Date:  1996-01-27       Impact factor: 79.321

10.  Presenting features of inflammatory bowel disease in Great Britain and Ireland.

Authors:  A Sawczenko; B K Sandhu
Journal:  Arch Dis Child       Date:  2003-11       Impact factor: 3.791

View more
  4 in total

1.  Increasing hospitalizations in inflammatory bowel disease among children in the United States, 1988-2011.

Authors:  Kelly C Sandberg; Matthew M Davis; Achamyeleh Gebremariam; Jeremy Adler
Journal:  Inflamm Bowel Dis       Date:  2014-10       Impact factor: 5.325

2.  Cost-effectiveness and Clinical Outcomes of Early Anti-Tumor Necrosis Factor-α Intervention in Pediatric Crohn's Disease.

Authors:  Naazish S Bashir; Thomas D Walters; Anne M Griffiths; Shinya Ito; Wendy J Ungar
Journal:  Inflamm Bowel Dis       Date:  2020-07-17       Impact factor: 5.325

3.  Surgical aspects of inflammatory bowel diseases in pediatric and adolescent age groups.

Authors:  Khaled El-Asmar; Ehab El-Shafei; Mohammed Abdel-Latif; Amr AbouZeid; Mosad El-Behery
Journal:  Int J Colorectal Dis       Date:  2015-09-26       Impact factor: 2.571

4.  Colonic perforation in a child with Crohn's disease: successful medical treatment rescues from colectomy.

Authors:  Marco Gasparetto; Benedetta Giorgi; Wolfgang Kleon; Faise Al Bunni; Graziella Guariso
Journal:  Case Rep Gastrointest Med       Date:  2012-09-29
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.